BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,300,822 | -19.2% | 34,468 | -2.4% | 0.05% | -13.3% |
| Q2 2023 | $1,609,134 | -6.5% | 35,319 | -16.7% | 0.06% | +1.7% |
| Q1 2023 | $1,720,312 | +92389.9% | 42,414 | +16.2% | 0.06% | +3.5% |
| Q4 2022 | $1,860 | -99.9% | 36,496 | -23.7% | 0.06% | -32.1% |
| Q3 2022 | $2,576,000 | -17.4% | 47,823 | -1.5% | 0.08% | -12.5% |
| Q2 2022 | $3,120,000 | -15.4% | 48,571 | +2.1% | 0.10% | 0.0% |
| Q1 2022 | $3,689,000 | -16.1% | 47,577 | -7.1% | 0.10% | -5.0% |
| Q4 2021 | $4,398,000 | +15.6% | 51,240 | +8.4% | 0.10% | -3.8% |
| Q3 2021 | $3,804,000 | -11.5% | 47,290 | -11.5% | 0.10% | -1.9% |
| Q2 2021 | $4,300,000 | -8.4% | 53,413 | -4.0% | 0.11% | -13.0% |
| Q1 2021 | $4,692,000 | -0.6% | 55,632 | -5.4% | 0.12% | -2.4% |
| Q4 2020 | $4,718,000 | +6.1% | 58,794 | +6.3% | 0.13% | -16.6% |
| Q3 2020 | $4,446,000 | -6.4% | 55,289 | +0.2% | 0.15% | -11.2% |
| Q2 2020 | $4,750,000 | +3.9% | 55,170 | -2.0% | 0.17% | +8.3% |
| Q1 2020 | $4,572,000 | +0.4% | 56,307 | +3.4% | 0.16% | +35.3% |
| Q4 2019 | $4,553,000 | -6.7% | 54,448 | -2.4% | 0.12% | -15.9% |
| Q3 2019 | $4,880,000 | +2.1% | 55,795 | -4.4% | 0.14% | +3.8% |
| Q2 2019 | $4,781,000 | +0.8% | 58,373 | +0.1% | 0.13% | -1.5% |
| Q1 2019 | $4,742,000 | +22.2% | 58,326 | -1.1% | 0.14% | +12.5% |
| Q4 2018 | $3,880,000 | -19.7% | 58,949 | -5.9% | 0.12% | -16.7% |
| Q3 2018 | $4,831,000 | -11.4% | 62,663 | -15.2% | 0.14% | -14.8% |
| Q2 2018 | $5,455,000 | -24.3% | 73,881 | -33.3% | 0.17% | +18.2% |
| Q1 2018 | $7,202,000 | -7.7% | 110,732 | -8.3% | 0.14% | -0.7% |
| Q4 2017 | $7,806,000 | +11.1% | 120,758 | +7.8% | 0.14% | +8.3% |
| Q3 2017 | $7,028,000 | +5.0% | 112,003 | +1.3% | 0.13% | +3.1% |
| Q2 2017 | $6,692,000 | +11.3% | 110,543 | -4.7% | 0.13% | +14.2% |
| Q1 2017 | $6,014,000 | +8.6% | 115,967 | -7.2% | 0.11% | +8.7% |
| Q4 2016 | $5,540,000 | -4.7% | 124,941 | +2.3% | 0.10% | -10.3% |
| Q3 2016 | $5,813,000 | -4.9% | 122,127 | -9.6% | 0.12% | -10.1% |
| Q2 2016 | $6,111,000 | +11.3% | 135,132 | +1.1% | 0.13% | +11.2% |
| Q1 2016 | $5,493,000 | +8.3% | 133,707 | +0.6% | 0.12% | +7.4% |
| Q4 2015 | $5,073,000 | -1.3% | 132,971 | -15.0% | 0.11% | -4.4% |
| Q3 2015 | $5,138,000 | -52.6% | 156,396 | +0.8% | 0.11% | -48.6% |
| Q2 2015 | $10,848,000 | +12.9% | 155,122 | +10.6% | 0.22% | +17.0% |
| Q1 2015 | $9,609,000 | -5.5% | 140,283 | +1.1% | 0.19% | -5.5% |
| Q4 2014 | $10,171,000 | +0.3% | 138,772 | -1.8% | 0.20% | -7.9% |
| Q3 2014 | $10,143,000 | -4.2% | 141,333 | -3.5% | 0.22% | -2.3% |
| Q2 2014 | $10,584,000 | -3.9% | 146,388 | -2.2% | 0.22% | -4.7% |
| Q1 2014 | $11,011,000 | +3.0% | 149,653 | -2.6% | 0.23% | +4.0% |
| Q4 2013 | $10,690,000 | -0.8% | 153,705 | -6.3% | 0.22% | -4.3% |
| Q3 2013 | $10,774,000 | -7.6% | 164,018 | -2.6% | 0.23% | -9.7% |
| Q2 2013 | $11,666,000 | – | 168,408 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |